journal article Open Access Aug 14, 2012

Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice

Abstract
Abstract
Introduction
The adult mammalian brain retains niches for neural stem cells (NSCs), which can generate glial and neuronal components of the brain tissue. However, it is barely established how chronic neuroinflammation, as it occurs in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, affects adult neurogenesis and, therefore, modulates the brain's potential for self-regeneration.

Methods
Neural stem cell culture techniques, intraventricular tumor necrosis factor (TNF)-α infusion and the 6-hydroxydopamine mouse model were used to investigate the influence of neuroinflammation on adult neurogenesis in the Parkinson's disease background. Microscopic methods and behavioral tests were used to analyze samples.

Results
Here, we demonstrate that differences in the chronicity of TNF-α application to cultured NSCs result in opposed effects on their proliferation. However, chronic TNF-α treatment, mimicking Parkinson's disease associated neuroinflammation, shows detrimental effects on neural progenitor cell activity. Inversely, pharmacological inhibition of neuroinflammation in a 6-hydroxydopamine mouse model led to increased neural progenitor cell proliferation in the subventricular zone and neuroblast migration into the lesioned striatum. Four months after surgery, we measured improved Parkinson's disease-associated behavior, which was correlated with long-term anti-inflammatory treatment. But surprisingly, instead of newly generated striatal neurons, oligodendrogenesis in the striatum of treated mice was enhanced.

Conclusions
We conclude that anti-inflammatory treatment, in a 6-hydroxydopamine mouse model for Parkinson's disease, leads to activation of adult neural stem cells. These adult neural stem cells generate striatal oligodendrocytes. The higher numbers of newborn oligodendrocytes possibly contribute to axonal stability and function in this mouse model of Parkinson's disease and thereby attenuate dysfunctions of basalganglian motor-control.
Topics

No keywords indexed for this article. Browse by subject →

References
51
[1]
Gandhi PN, Chen SG, Wilson-Delfosse AL: Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease. J Neurosci Res. 2009, 87: 1283-1295. 10.1002/jnr.21949. 10.1002/jnr.21949
[2]
Gao HM, Hong JS: Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 2008, 29: 357-365. 10.1016/j.it.2008.05.002. 10.1016/j.it.2008.05.002
[3]
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F: Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973, 20: 415-455. 10.1016/0022-510X(73)90175-5. 10.1016/0022-510x(73)90175-5
[4]
Ming GL, Song H: Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron. 2011, 70: 687-702. 10.1016/j.neuron.2011.05.001. 10.1016/j.neuron.2011.05.001
[5]
Palm T, Bahnassawy L, Schwamborn J: miRNAs and neural stem cells: a team to treat Parkinson's disease?. RNA Biol. 2012, 9: Epub ahead of print
[6]
Alvarez-Buylla A, Lim DA: For the long run: maintaining germinal niches in the adult brain. Neuron. 2004, 41: 683-686. 10.1016/S0896-6273(04)00111-4. 10.1016/s0896-6273(04)00111-4
[7]
Mechanisms and Functional Implications of Adult Neurogenesis

Chunmei Zhao, Wei Deng, Fred H. Gage

Cell 2008 10.1016/j.cell.2008.01.033
[8]
Hoehn BD, Palmer TD, Steinberg GK: Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke. 2005, 36: 2718-2724. 10.1161/01.STR.0000190020.30282.cc. 10.1161/01.str.0000190020.30282.cc
[9]
Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O: Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med. 2002, 8: 963-970. 10.1038/nm747. 10.1038/nm747
[10]
Nakaguchi K, Masuda H, Kaneko N, Sawamoto K: Strategies for regenerating striatal neurons in the adult brain by using endogenous neural stem cells. Neurol Res Int. 2011, 2011: 898012- 10.1155/2011/898012
[11]
Cooper O, Isacson O: Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons. J Neurosci. 2004, 24: 8924-8931. 10.1523/JNEUROSCI.2344-04.2004. 10.1523/jneurosci.2344-04.2004
[12]
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

P. L. McGeer, S. Itagaki, B. E. Boyes et al.

Neurology 1988 10.1212/wnl.38.8.1285
[13]
Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O: Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci. 2002, 15: 991-998. 10.1046/j.1460-9568.2002.01938.x. 10.1046/j.1460-9568.2002.01938.x
[14]
Conti L, Pollard SM, Gorba T, Reitano E, Toselli M, Biella G, Sun Y, Sanzone S, Ying QL, Cattaneo E, Smith A: Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 2005, 3: e283-10.1371/journal.pbio.0030283. 10.1371/journal.pbio.0030283
[15]
Hillje AL, Worlitzer MM, Palm T, Schwamborn JC: Neural stem cells maintain their stemness through protein kinase C zeta-mediated inhibition of TRIM32. Stem Cells. 2011, 29: 1437-1447. 10.1002/stem.687
[16]
da Conceicao FS, Ngo-Abdalla S, Houzel JC, Rehen SK: Murine model for Parkinson's disease: from 6-OH dopamine lesion to behavioral test. J Vis Exp. 2010, pii:1376
[17]
He Y, Appel S, Le W: Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res. 2001, 909: 187-193. 10.1016/S0006-8993(01)02681-6. 10.1016/s0006-8993(01)02681-6
[18]
Bilousova TV, Dansie L, Ngo M, Aye J, Charles JR, Ethell DW, Ethell IM: Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile × mouse model. J Med Genet. 2009, 46: 94-102. 10.1136/jmg.2008.061796
[19]
Bastos GN, Moriya T, Inui F, Katura T, Nakahata N: Involvement of cyclooxygenase-2 in lipopolysaccharide-induced impairment of the newborn cell survival in the adult mouse dentate gyrus. Neuroscience. 2008, 155: 454-462. 10.1016/j.neuroscience.2008.06.020. 10.1016/j.neuroscience.2008.06.020
[20]
CellProfiler: image analysis software for identifying and quantifying cell phenotypes

Anne E Carpenter, Thouis R Jones, Michael R Lamprecht et al.

Genome Biology 2006 10.1186/gb-2006-7-10-r100
[21]
Cell Profiler - cell image analysis software. [http://www.cellprofiler.org/]
[22]
Mechanisms Underlying Inflammation in Neurodegeneration

Christopher K. Glass, Kaoru Saijo, Beate Winner et al.

Cell 2010 10.1016/j.cell.2010.02.016
[23]
Griffiths MR, Gasque P, Neal JW: The multiple roles of the innate immune system in the regulation of apoptosis and inflammation in the brain. J Neuropathol Exp Neurol. 2009, 68: 217-226. 10.1097/NEN.0b013e3181996688. 10.1097/nen.0b013e3181996688
[24]
Crosio C, Casciati A, Iaccarino C, Rotilio G, Carri MT: Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis. Cell Death Differ. 2006, 13: 2150-2153. 10.1038/sj.cdd.4401943. 10.1038/sj.cdd.4401943
[25]
Jeon BS, Jackson-Lewis V, Burke RE: 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration. 1995, 4: 131-137. 10.1006/neur.1995.0016. 10.1006/neur.1995.0016
[26]
Yong VW, Wells J, Giuliani F, Casha S, Power C, Metz LM: The promise of minocycline in neurology. Lancet Neurol. 2004, 3: 744-751. 10.1016/S1474-4422(04)00937-8. 10.1016/s1474-4422(04)00937-8
[27]
Pizza V, Agresta A, D'Acunto CW, Festa M, Capasso A: Neuroinflammation and ageing: current theories and an overview of the data. Rev Recent Clin Trials. 2011, 6: 189-203. 10.2174/157488711796575577. 10.2174/157488711796575577
[28]
Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system

Urban Ungerstedt, Gordon W. Arbuthnott

Brain Research 1970 10.1016/0006-8993(70)90187-3
[29]
van den Berge SA, van Strien ME, Korecka JA, Dijkstra AA, Sluijs JA, Kooijman L, Eggers R, De Filippis L, Vescovi AL, Verhaagen J, van de Berg WD, Hol EM: The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain. Brain. 2011, 134: 3249-3263. 10.1093/brain/awr256. 10.1093/brain/awr256
[30]
Hoglinger GU, Rizk P, Muriel MP, Duyckaerts C, Oertel WH, Caille I, Hirsch EC: Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci. 2004, 7: 726-735. 10.1038/nn1265. 10.1038/nn1265
[31]
Baker SA, Baker KA, Hagg T: Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur J Neurosci. 2004, 20: 575-579. 10.1111/j.1460-9568.2004.03486.x. 10.1111/j.1460-9568.2004.03486.x
[32]
Russo I, Barlati S, Bosetti F: Effects of neuroinflammation on the regenerative capacity of brain stem cells. J Neurochem. 2011, 116: 947-956. 10.1111/j.1471-4159.2010.07168.x. 10.1111/j.1471-4159.2010.07168.x
[33]
Das S, Dutta K, Kumawat KL, Ghoshal A, Adhya D, Basu A: Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS One. 2011, 6: e17225-10.1371/journal.pone.0017225. 10.1371/journal.pone.0017225
[34]
Winner B, Couillard-Despres S, Geyer M, Aigner R, Bogdahn U, Aigner L, Kuhn HG, Winkler J: Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration. J Neuropathol Exp Neurol. 2008, 67: 105-116. 10.1097/nen.0b013e3181630cff. 10.1097/nen.0b013e3181630cff
[35]
Ng SY, Semple B, Morganti-Kossmann MC, Bye N: Attenuation of microglial activation with minocycline is not associated with changes in neurogenesis after focal traumatic brain injury in adult mice. J Neurotrauma. 2012
[36]
Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A: Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA. 2007, 104: 4694-4699. 10.1073/pnas.0606835104. 10.1073/pnas.0606835104
[37]
Picard-Riera N, Decker L, Delarasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D, Evercooren AB: Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci USA. 2002, 99: 13211-13216. 10.1073/pnas.192314199. 10.1073/pnas.192314199
[38]
Braak H, Del Tredici K: Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging. 2004, 25: 19-23. 10.1016/j.neurobiolaging.2003.04.001. 10.1016/j.neurobiolaging.2003.04.001
[39]
Juurlink BH: Response of glial cells to ischemia: roles of reactive oxygen species and glutathione. Neurosci Biobehav Rev. 1997, 21: 151-166. 10.1016/S0149-7634(96)00005-X. 10.1016/s0149-7634(96)00005-x
[40]
Jurewicz A, Matysiak M, Tybor K, Selmaj K: TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3. Brain. 2003, 126: 1358-1370. 10.1093/brain/awg146. 10.1093/brain/awg146
[41]
Jurewicz A, Matysiak M, Tybor K, Kilianek L, Raine CS, Selmaj K: Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain. 2005, 128: 2675-2688. 10.1093/brain/awh627. 10.1093/brain/awh627
[42]
Miklossy J, Arai T, Guo JP, Klegeris A, Yu S, McGeer EG, McGeer PL: LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol. 2006, 65: 953-963. 10.1097/01.jnen.0000235121.98052.54. 10.1097/01.jnen.0000235121.98052.54
[43]
Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H: NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol. 2000, 99: 14-20. 10.1007/PL00007400. 10.1007/pl00007400
[44]
Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, Beyreuther K, Masters CL, Li QX: The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. J Neurochem. 2001, 76: 87-96. 10.1046/j.1471-4159.2001.00021.x
[45]
Takagi S, Hayakawa N, Kimoto H, Kato H, Araki T: Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice. J Neural Transm. 2007, 114: 1553-1557. 10.1007/s00702-007-0790-9. 10.1007/s00702-007-0790-9
[46]
Cacci E, Ajmone-Cat MA, Anelli T, Biagioni S, Minghetti L: In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia. Glia. 2008, 56: 412-425. 10.1002/glia.20616. 10.1002/glia.20616
[47]
Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O: Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA. 2003, 100: 13632-13637. 10.1073/pnas.2234031100. 10.1073/pnas.2234031100
[48]
Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S, Kokaia Z, Jacobsen SE, Lindvall O: Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci. 2006, 26: 9703-9712. 10.1523/JNEUROSCI.2723-06.2006. 10.1523/jneurosci.2723-06.2006
[49]
Widera D, Mikenberg I, Elvers M, Kaltschmidt C, Kaltschmidt B: Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci. 2006, 7: 64-10.1186/1471-2202-7-64. 10.1186/1471-2202-7-64
[50]
Johansson S, Price J, Modo M: Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells. Stem Cells. 2008, 26: 2444-2454. 10.1634/stemcells.2008-0116. 10.1634/stemcells.2008-0116

Showing 50 of 51 references

Metrics
19
Citations
51
References
Details
Published
Aug 14, 2012
Vol/Issue
3(4)
License
View
Cite This Article
Maik MA Worlitzer, Eva C Bunk, Kathrin Hemmer, et al. (2012). Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice. Stem Cell Research & Therapy, 3(4). https://doi.org/10.1186/scrt124